The page is the record's research on the issuer — no analyst, no rating, no view. # Emergent BioSolutions Inc. (NYSE: EBS) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing Emergent BioSolutions Inc. is listed on the NYSE under ticker EBS, with ISIN US29089Q1058 and LEI 549300YW6TUOX8BE5103. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States — Delaware. Its segment is not on the record. Its listing status is listed, not halted. ## The disclosure read The record holds 97 filings across 52 filing days in the twelve months to 2026-11-08. The median gap between filing days is 4 days. The median gap for NYSE issuers is 6.0 days, and for the 2834 Pharmaceutical Preparations sector it is 6.0 days. The latest filing is a corporate_news filing dated 2026-11-04, 4 days before the record date. The median latency is 4.0 days for the exchange and 4.0 days for the sector. ## Auditor The auditor of record is Ernst & Young LLP, located in Tysons, Virginia. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change entries. Domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. Segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations page, and the count is 0. ## Open research No openly published research notes were found, and the count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's sealed years are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001367644.json (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.us-cm-kg.ai/events/NYSE/EBS (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1367644/000136764426000015/ebs-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NYSE/EBS (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NYSE/EBS · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp